FFilingSight

DexCom Inc. (DXCM) 10-K Red Flags

Risk signals extracted deterministically from DexCom Inc.’s SEC 10-K/10-Q XBRL filings — no LLM, every finding cites the underlying data.

Detected red flags (9)

  • Operating cash flow exceeds net income: OCF is 1.72x net income, indicating high earnings quality — cash conversion is strong and accruals are not inflating reported profits.
  • NEW: Impairment charge: Impairment charge appears in recent filings but not in the prior 24-month period. Monitor for materiality.
  • NEW: Off-balance sheet arrangements: Off-balance sheet arrangements appears in recent filings but not in the prior 24-month period. Monitor for materiality.
  • Endogenous analysis: 1 positive signal(s) versus 0 risk signal(s). The filing exhibits more constructive indicators than concerns, though individual risk factors should still be monitored.
  • 6 new XBRL disclosure(s) in latest filing — expanding reporting scope.
  • 20 disclosure(s) dropped from prior year — reduced reporting granularity.
  • 2 new risk-language term(s) detected in filing text: Impairment charge, Off-balance sheet arrangements.
  • Market cap $33.81B at $89.60 per share.
  • Trailing P/E 42.87, P/S 7.25, P/B 12.90.

Filings & ownership

  • Latest annual report (10-K) filed Feb 12, 2026.
  • Latest quarterly report (10-Q) filed Jul 30, 2026.
  • 13 recent 8-K material-event filings in the index.
  • Recent insider Form 4s: 0 buy vs 0 sell transactions.
  • ~10,000+ recent 13F-HR filings reference DexCom Inc.; broad institutional reporting.
  • Recent filers include PURA VIDA INVESTMENTS, LLC, Rothschild Capital Partners, LLC, WS MANAGEMENT LLLP.
  • 20 recent 13G passive institutional ownership notices.

Full DXCM analyst report

Valuation (DCF & Graham), technicals, macro exposure, risk scorecard and 13F/13D ownership.

View full report →

Not investment advice. FilingSight is an automated analytical research tool, not a registered investment advisor. Ratings and scores are quantitative analytical classifications, not buy or sell recommendations. Nothing here is personalized to your circumstances. Investing involves risk of loss — consult a licensed professional. See full disclosures.